Work

Imatinib mesylate (STI-571, Gleevec®) offers combinatorial benefit with temozolomide (Temodar®) against gliomas

Year: 2005

Type: article

Source: Cancer Research

Authors: Jeremy N. Rich, Stephen T. Keir, Sith Sathornsumetee, David A. Reardon, Darell D. Bigner, Henry S. Friedman

Institutions: Duke University, Duke Medical Center

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1526864158

FWCI:

Cites:

Cited by:

Related to: 20